Viral infection among patients with hemophilia in the Southeast of Iran

Journal of Medical Sciences

Volumn 6, Issue 2, 2006, Pages 225-228

  Sharifi Mood, Batool ^a   Sanei Moghaddam, Smail ^b   Salehi, Masoud ^a   Eshghi, Payman ^a   Khosravi, Soheila ^a   Khalili, Manijeh ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Hemophilia; Hepatitis B surface antigen; Hepatitis C HIV; Prevalence

Indexed keywords

BLOOD CLOTTING FACTOR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPHILIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RACE DIFFERENCE; SEROPREVALENCE; WESTERN BLOTTING;

EID: 33645365786     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.225.228     Document Type: Article

References (18)

1. Alter, H.J., R.H. Purcell and J.W. Shih et al., 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med., 321: 1494-1500.
2. Anonymous, 1992. HIV infection in two brothers receiving intravenous therapy for hemophilia. MMWR, 41: 228-231.
3. Anonymous, 1994. Human immunodeficiency virus transmission in household settings. United States. MMWR, 347: 353-356.
4. Alter, M.J., 1995. Epidemiology of hepatitis C in the West. Semin. Liv. Dis., 15: 5-14.
5. Anonymous, 1995. Morbidity and Mortality Weekly Report: Hepatitis A among persons with hemophilia who received clotting factor concentrate. United States, Sept-Dec. MMWR, 42: 29.
6. Anonymous, 1997. Transmission of Hepatitis C Virus Infection Associated Home Infusion Therapy for Hemophilia, MMWR, 26: 597-599.
7. Bray, G.L., E.D. Gomperts and S. Courter et al., 1994. A multicenter study of recombinant factor VIII (Recombinate): Safety, efficacy and inhibitor risk in previously untreated patients with hemophilia A. Blood, 83: 2428-2835.
8. Goedert, J.J., M.E. Eyster, M.M. Ledreman and T. Mandalaki et al., 2002. End stage liver diseases in persons with hemophilia and transfusion-associated infections. Blood, 5: 1584-1589.
9. Kasper, C.K. and J.M. Lusher, 1993. Transfusion Practices Committee. Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion, 33: 422-434.
10. Kazimierska, E. and J. Gorski, 1989. Anti-HBs, anti-CMV, anti-HIV and HBsAg in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma. Acta. Haematol., 2: 189-194.
11. Lawrence, JR., 1994. Viral safety and final product manufacturing testing and specifications. Ann Hematol, 68: (suppl 3): S21-S24.
12. Lobato, M.N., M.J. Oxtoby, L. Augustyniak and M.B. Caldwell et al., 1996. Infection control practices in the home: A survey of households of HIV-infected persons with hemophilia. Infect. Control Hosp. Epidemiol., 17: 721-725.
13. Makris, M., F.E. Preston and D.R. Triger et al., 1990. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet, 335: 1117-1119.
14. Matania, T., M.S. Triemstra, R. Frits and M.D. Rosendaal et al., 1995. Mortality in Patients with Hemophilia. Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986. Ann. Intl. Med., 11: 823-827.
15. Mauser-Bunschoten, E.P., D. Bresters, A.A. Drimmelen and G. Roosendaal et al., 1995. Hepatitis C infection and viremia in Dutch hemophilia patients. J. Med. Virol., 45: 241.
16. Rosenberg, P.S. and J.J. Goedert, 1998. Estimating the cumulative incidence of HIV infection among persons eith hemophilia in the united States of America. Stat. Med., 17: 155-168.
17. Smith, P.S. and P.H. Levine, 1984. The benefits of comprehensive care of hemophilia: A five-year study of outcomes. Am. J. Public Health, 74: 616-617.
18. Troisi, C.L., F.B. Hollinger and W.K. Hoots et al., 1993. A multicenter study of viral hepatitis in a United States hemophilic population. Blood, 81: 412-418.